NOYORI Chiral Homogeneous Hydrogenation

NIEMENTOWSKI Quinarolone synthesis 275 NOYORI Chiral homogeneous hydrogenation 276 277... 

NOYORI Chiral homogeneous hydrogenation Homogeneous chiral hydrogenation ot unsaluraled alcohols, or carboxylic acids, enamldes, ketones in the presence ot BINAP Ru or Rh complex 8 as catalyst. 

The standard work of Evans [2] as well as a survey of the papers produced in the Journal of Labeled Compounds and Radiopharmaceuticals over the last 20 years shows that the main tritiation routes are as given in Tab. 13.1. One can immediately see that unlike most 14C-labeling routes they consist of one step and frequently involve a catalyst, which can be either homogeneous or heterogeneous. One should therefore be able to exploit the tremendous developments that have been made in catalysis in recent years to benefit tritiation procedures. Chirally catalyzed hydrogenation reactions (Knowles and Noyori were recently awarded the Nobel prize for chemistry for their work in this area, sharing it with Sharpless for his work on the equivalent oxidation reactions) immediately come to mind. Already optically active compounds such as tritiated 1-alanine, 1-tyrosine, 1-dopa, etc. have been prepared in this way. 

Enantioselective homogeneous hydrogenation catalyzed by chiral transition metal complexes is one of the most well established transformations in asymmetric synthesis [1]. Excellent enantioselectivities have been achieved in the hydrogenation of a wide range of substrates, often with very low catalyst loadings. High reliability, mild reaction conditions, and perfect atom economy are further attractive attributes of this method. In particular complexes based on Ru or Rh have found broad application in industrial processes [1] and the impact of these catalysts has been recognized by the Nobel Prize awarded to Ryoji Noyori and William S. Knowles in 2001 [2]. 

University). (The other half of the 2001 prize was awarded to K. B. Sharpless for asymmetric oxidation reactions. See Chapter 8.) Knowles, Noyori, and others developed chiral catalysts for homogeneous hydrogenation that have proved extraordinarily useful for enantioselective syntheses ranging from small laboratory-scale reactions to industrial- (ton-) scale reactions. An important example is the method developed by Knowles and co-workers at Monsanto Corporation for synthesis of l-DOPA, a compound used in the treatment of Parkinson s disease ... 

The first transition metal catalysis using BINAP-ruthenium complex in homogeneous phase for enantioselective hydrogenation of P-ketoesters was developed by Noyori and co-workers [31]. Genet and co-workers described a general synthesis of chiral diphosphine ruthenium(II) catalysts from commercially available (COD)Ru(2-methylallyl)2 [32]. These complexes preformed or prepared in situ have been found to be very efficient homogeneous catalysts for asymmetric hydrogenation of various substrates such as P-ketoesters at atmospheric pressure and at room temperature [33]. 

Homogeneous catalytic asymmetric hydrogenation has become one of the most efficient methods for the synthesis of chiral alcohols, amines, a and (3-amino acids, and many other important chiral intermediates. Specifically, catalytic asymmetric hydrogenation methods developed by Professor Ryoji Noyori are highly selective and efficient processes for the preparation of a wide variety of chiral alcohols and chiral a-amino acids.3 The transformation utilizes molecular hydrogen, BINAP (2,2 -bis(diphenylphosphino)-l,l -binaphthyl) ligand and ruthenium(II) or rhodium(I) transition metal to reduce prochiral ketones 1 or olefins 2 to their corresponding alcohols 3 or alkanes 4, respectively.4... 

---